Peak no.a | t R (min) | UV λmax | MSn (m/z) and relative abundance (% base peak) | Identification |
---|---|---|---|---|
1 | 14.0 | 215, 275, 318 | APCI+—MS: 549(100); MS2 [549]: 531(70), 513(60), 495(90), 483(20), 465(45), 429(10), 411(100), 393(30), 363(10); MS3 [411]: 393(100), 375(60), 363(70), 333(80), 309(30), 279(28) APCI−—MS: 547(100); MS2 [547]: 529(20), 511(10), 487(85), 457(100), 427(42), 409(10), 367(60), 337(70); MS3 [457]: 367(10), 337(100) | Chrysin-6-C-arabinosyl-8-C-glucosidec |
2 | 17.6 | 215, 275, 318 | APCI+—MS: 549(100); MS2 [549]: 531(100), 513(30), 495(20), 483(45), 465(20), 453(18), 441(18), 411(10), 393(8), 381(6); MS3 [531]: 513(80), 495(60), 483(100), 465(75), 453(70), 441(60), 411(12), 393(30), 381(50), 363(40) APCI−—MS: 547(100); MS2 [547]: 529(15), 487(15), 457(70), 427(100), 367(20), 337(30); MS3 [427]: 367(15), 337(100) | Chrysin-6-C-glucosyl-8-C-arabinosidec |
3 | 27.3 | 215, 277, 316 | APCI+—MS: 447(100), 271(20); MS2 [447]: 271(100); MS3 [271]: 253(40), 241(100) APCI−—MS: 559(100); MS2 [559]: 445(100); MS3 [445]: 269(100) | Baicalinb |
4 | 29.7 | 215, 280, 360 | APCI+—MS: 447(100), 271(20); MS2 [447]: 271(100) APCI−—MS: 559(20), 445(100); MS2 [559]: 445(100); MS3 [445]: 269(100) | Norwogonin-7-O-glucuronidec |
5 | 30.8 | 215, 273, 312 | APCI+ – MS: 431(100), 255(20); MS2 [431]: 255(100) APCI−—MS: 543(100); MS2 [543]: 429(100); MS3 [429]: 253(100), 173(40) | Chrysin-7-O-glucuronidec |
6 | 32.3 | 215, 275, 349 | APCI+—MS: 461(100); MS2 [461]: 285(100); MS3 [285]: 270(100) APCI−—MS: 573(100); MS2 [573]: 459(100); MS3 [459]: 283(100), 268(20), 174(30) | Wogonosideb |
7 | 40.1 | 215, 275, 322 | APCI+—MS: 271(100); MS2 [271]: 241(100) | Baicaleinb |
8 | 48.0 | 210, 275 | APCI+—MS: 285(100); MS2 [285]: 270(100) | Wogoninb |
9 | 50.5 | 215, 273, 318 | APCI+—MS: 285(100); MS2 [285]: 270(100) | Oroxylin Ac |